Search
Menu
Rocky Mountain Instruments - Infrared Optics LB

Leica Microsystems, CMED Collaborate on FISH Kits

Facebook X LinkedIn Email
BEIJING & WETZLAR, Germany, Aug. 12, 2011 — In vitro diagnostic company China Medical Technologies Inc. (CMED) and Leica Biosystems, a division of Leica Microsystems, have established a sales, research and development collaboration to develop and market FISH kits for the Leica Bond system, an automated staining platform.

The two companies will develop automated solutions for tissue sample tests on HER-2, EGFR and TOP2A genes, all three of which play a role in targeted drug therapy for breast, lung and stomach cancer patients.

Both parties have agreed to work together on additional FISH applications during the term, including those relevant to prenatal care and cytology.

In addition, they have agreed that CMED will sell the FISH kits in China, while Leica will have the option to sell them in the rest of the world.

Leica Microsystems develops microscopes and scientific instruments. Its Biosystems Div. offers products for histopathology laboratories.

For more information, visit: www.leica-microsystems.com  
CASTECH INC - High Precision CNC Polished Aspherical Lenses


Published: August 2011
Asia-Pacificautomated FISH kitsBiophotonicsbreast cancer drug therapyBusinesscancer therapy drugsChinaChina Medical Technologies Inc.CMEDcytologyEGFR geneEuropeFISH kitsGermanyHER-2 genehistopathologyImagingin vitro diagnosticsLeica BiosystemsLeica BONDLeica Microsystemslung cancer drug therapymicroscopesMicroscopyprenatal applicationsstaining platformstomach cancer drug therapytissue sample testsTOP2A gene

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.